A trial looking at monalizumab for head and neck cancer that has spread or come back (INTERLINK 1)

This trial is looking at adding monalizumab to cetuximab for people who have squamous cell cancer of the head and neck.

The trial is open to people whose cancer has come back or spread to another part of the body.

It is for people who have one of the following types of head and neck cancer:

• mouth and oropharyngeal cancer

• cancer of the area that surrounds the voice box (hypopharynx)

• cancer of the voice box (laryngeal cancer)